Incannex Healthcare Limited (IXHL)
IXHL Stock Price Chart
Explore Incannex Healthcare Limited interactive price chart. Choose custom timeframes to analyze IXHL price movements and trends.
IXHL Company Profile
Discover essential business fundamentals and corporate details for Incannex Healthcare Limited (IXHL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2 Mar 2022
Employees
9.00
Website
https://www.incannex.com.auCEO
Joel Bradley Latham
Description
Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.
IXHL Financial Timeline
Browse a chronological timeline of Incannex Healthcare Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 12 Feb 2026
Upcoming earnings on 12 Nov 2025
Upcoming earnings on 29 Sept 2025
EPS estimate is -$0.29.
Earnings released on 15 May 2025
EPS came in at -$0.24 surpassing the estimated -$0.46 by +47.83%.
Earnings released on 14 Feb 2025
EPS came in at -$0.33 surpassing the estimated -$0.70 by +52.86%, while revenue for the quarter reached $7.43K , missing expectations by -95.27%.
Earnings released on 14 Nov 2024
EPS came in at -$10.83 falling short of the estimated -$0.76 by -1.33K%, while revenue for the quarter reached $51.20K , missing expectations by -66.97%.
Earnings released on 30 Sept 2024
EPS came in at -$0.39 surpassing the estimated -$0.72 by +45.53%, while revenue for the quarter reached $8.00K .
Earnings released on 15 May 2024
EPS came in at -$0.38 .
Earnings released on 26 Feb 2024
EPS came in at -$0.22 .
Earnings released on 1 Dec 2023
EPS came in at -$0.03 .
Stock split effective on 30 Nov 2023
Shares were split 1 : 4 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Oct 2023
EPS came in at -$0.01 .
Earnings released on 30 Mar 2023
EPS came in at -$0.15 .
Earnings released on 31 Dec 2022
EPS came in at -$0.13 .
Earnings released on 28 Oct 2022
EPS came in at -$0.01 , while revenue for the quarter reached $185.70K .
Earnings released on 30 Sept 2022
EPS came in at -$0.89 .
Earnings released on 2 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $219.62K .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 .
Earnings released on 30 Sept 2021
EPS came in at -$0.00 .
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $202.79K .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $208.31K .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $348.02K .
Earnings released on 30 Sept 2020
EPS came in at -$0.00 , while revenue for the quarter reached $301.93K .
IXHL Stock Performance
Access detailed IXHL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.